Salubrinal, Fenoldopam, and Taxol were employed as control agents, which were the modulator of p-eIF2α, DRD1 agonist, and a chemotherapeutic agent for breast cancer, respectively *(Suppl. Here, EIF2A is linked to breast carcinoma.